aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension
RxNorm concept 252203, clinical drug (scd). Prescribable name: aluminum hydroxide 95 MG / magnesium carbonate 358 MG in 15 mL Oral Suspension.
- RxCUI
- 252203
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/252203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG per 5 ML Oral Suspension; aluminum hydroxide 32 MG / magnesium carbonate 119 MG per 5 ML Oral Suspension; aluminum hydroxide 95 MG / magnesium carbonate 358 MG per 15 ML Oral Suspension
Related concepts
- aluminum hydroxide 6.33 MG/ML (SCDC, consists of)
- magnesium carbonate 23.9 MG/ML (SCDC, consists of)
- Oral Suspension (DF, has dose form)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Acid Gone] (SBD, has tradename)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] (SBD, has tradename)
Linked data
NDCs
- 24385039740
- 57896061712
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 252203 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/252203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 252203. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.